Cancer Immunology, Immunotherapy

Epigenetic regulation of immune escape genes in cancer

• Review

Thomas B. Tomasi, William J. Magner, A. Nazmul H. Khan

Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites

• Original Article

Helena Harlin, Todd V. Kuna, Amy C. Peterson, Yuru Meng, Thomas F. Gajewski

Telomere length of in vivo expanded CD4+CD25+ regulatory T-cells is preserved in cancer patients

• Original Article

Dominik Wolf, Holger Rumpold, Christian Koppelstätter, Guenther A. Gastl, Michael Steurer, Gert Mayer, Eberhard Gunsilius, Herbert Tilg, Anna M. Wolf

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

• Original Article

Joseph W. Fay, A. Karolina Palucka, Sophie Paczesny, Madhav Dhodapkar, Dennis A. Johnston, Susan Burkeholder, Hideki Ueno, Jacques Banchereau

Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion

• Original Article

Uhi Toh, Teruhiko Fujii, Naoko Seki, Fumihiko Niiya, Kazuo Shirouzu, Hideaki Yamana

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses

• Original Article

Claudia Falkensammer, Karin Jöhrer, Hubert Gander, Reinhold Ramoner, Thomas Putz, Andrea Rahm, Richard Greil, Georg Bartsch, Martin Thurnher

Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells

• Original Article

Shari Pilon-Thomas, Monique Verhaegen, Lisa Kuhn, Adam Riker, James J Mulé

The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients

• Original Article

Margarita Skopeliti, Ioannis F. Voutsas, Persefoni Klimentzou, Marinos L. Tsiatas, Alexander Beck, Aristotelis Bamias, Maria Moraki, Evangelia Livaniou, Monica Neagu, Wolfgang Voelter, Ourania E. Tsitsilonis

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses

• Original Article

Yunfei Gao, Dongqing Zhang, Buxiang Sun, Hajime Fujii, Ken-Ichi Kosuna, Zhinan Yin

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model

• Original Article

Zhengrong Cui, Fu Qiu

Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique

• Original Article

Anette Knudsen, Sissel E. Monstad, Anne Dørum, Per E. Lønning, Helga B. Salvesen, Lars Drivsholm, Jan H. Aarseth, Christian A. Vedeler

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration

• Original Article

Rodney A. Prell, Lisa Gearin, Andrew Simmons, Melinda VanRoey, Karin Jooss

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

• Short Communication

Marion Wobser, Petra Keikavoussi, Volker Kunzmann, Markus Weininger, Mads H. Andersen, Juergen C. Becker

Acknowledgement to our reviewers 2005

• Acknowledgement to Reviewers